A Glimpse Into The Expert Outlook On Accolade Through 7 Analysts
Portfolio Pulse from Benzinga Insights
Accolade (NASDAQ:ACCD) has received mixed ratings from 7 analysts over the last quarter, with recent sentiment showing 1 bullish rating in the last 30 days compared to 2 bullish and 2 somewhat bullish ratings 1 month ago. The 12-month price target average has increased to $14.71, up 8.96% from the previous $13.50, with a high estimate of $17.00 and a low of $12.00. Analysts from firms including Needham, Truist Securities, Piper Sandler, Wells Fargo, Raymond James, and Stifel have updated their ratings and price targets, reflecting their views on Accolade's market performance and financials. Accolade's financial indicators show a positive revenue trend with a growth rate of 9.26% as of November 30, 2023, but it has a net margin of -21.2% and ROE of -4.83%, indicating potential profitability and efficiency challenges.
January 19, 2024 | 12:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Accolade has seen a recent increase in its 12-month price target average to $14.71, indicating a positive outlook from analysts despite mixed ratings. Financial indicators show growth but also highlight profitability and efficiency challenges.
The increase in the average price target suggests a positive short-term outlook for ACCD's stock price, as analysts are generally optimistic about the company's future performance. However, the mixed ratings and concerns over profitability and efficiency could temper the stock's upward momentum. The relevance is high as the article is directly about ACCD's analyst ratings and price targets. The importance is significant as analyst ratings can influence investor sentiment and stock price. The confidence level is moderately high, reflecting the clear trend in analyst sentiment and the detailed financial data provided.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100